Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00075062 · ClinicalTrials.gov registry record
A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 16
- Enrollment target
NCT00075062 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 16 participants.
The verdict
NCT00075062 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Microbicides are drugs that destroy microbes such as viruses and bacteria. Rectal microbicides may be able to prevent transmission of HIV during anal intercourse. The purpose of this study is to obtain rectal samples from men to learn information that may be valuable in future clinical trials of rectal microbicides.
Interventions
- PROCEDURE Rectal Biopsy
- PROCEDURE Flexible Sigmoidoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00075062
The ClinicalTrials.gov registry entry for NCT00075062 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Rectal Biopsy is the first listed.
NCT00075062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00075062 about?
NCT00075062 is a clinical study titled "A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials". Microbicides are drugs that destroy microbes such as viruses and bacteria. Rectal microbicides may be able to prevent transmission of HIV during anal intercourse. The purpose of this study is to obtain rectal samples from men to learn information that may be valuable in future clinical trials of rec...
What is the current status of trial NCT00075062?
This trial is currently completed. The enrollment target is 16 participants.
What interventions are being tested in trial NCT00075062?
The interventions under investigation include: Rectal Biopsy (PROCEDURE), Flexible Sigmoidoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00075062?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.